Muna Almaslamani
Office of Infectious Diseases(US)Hamad Medical Corporation(QA)Qatar University(QA)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Antifungal resistance and susceptibility, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Tocilizumab for the treatment of severe coronavirus disease 2019(2020)268 cited
- → A living WHO guideline on drugs to prevent covid-19(2021)149 cited
- → Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant(2022)131 cited
- → Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19(2021)74 cited
- → Epidemiology of bacteraemia in Hamad general hospital, Qatar: A one year hospital-based study(2010)72 cited
- → One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar(2021)72 cited
- → NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues